Matthew K Fust - Net Worth and Insider Trading
Matthew K Fust Net Worth
The estimated net worth of Matthew K Fust is at least $1 Million dollars as of 2025-04-18. Matthew K Fust is the Director of Crinetics Pharmaceuticals Inc and owns about 18,536 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $563,865. Matthew K Fust is the Director of Ultragenyx Pharmaceutical Inc and owns about 14,860 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $530,353. Matthew K Fust is also the Director of Dermira Inc and owns about 5,051 shares of Dermira Inc (DERM) stock worth over $94,706. Besides these, Matthew K Fust also holds Neumora Therapeutics Inc (NMRA) , Atara Biotherapeutics Inc (ATRA) , Macrogenics Inc (MGNX) . Details can be seen in Matthew K Fust's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew K Fust has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Matthew K Fust
Matthew K Fust Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew K Fust owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and Atara Biotherapeutics Inc (ATRA) among others .
Click here to see the complete history of Matthew K Fust’s form 4 insider trades.
Insider Ownership Summary of Matthew K Fust
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-07 | director |
CRNX | Crinetics Pharmaceuticals Inc | 2024-03-20 | director |
ATRA | Atara Biotherapeutics Inc | 2021-11-04 | director |
![]() | ![]() | 2020-02-20 | director |
![]() | ![]() | 2019-02-06 | director |
![]() | ![]() | 2007-05-31 | Senior Vice President & CFO |
![]() | ![]() | 2024-10-18 | director |
Matthew K Fust Latest Holdings Summary
Matthew K Fust currently owns a total of 6 stocks. Among these stocks, Matthew K Fust owns 18,536 shares of Crinetics Pharmaceuticals Inc (CRNX) as of March 20, 2024, with a value of $563,865 and a weighting of 46.59%. Matthew K Fust owns 14,860 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 7, 2024, with a value of $530,353 and a weighting of 43.82%. Matthew K Fust also owns 5,051 shares of Dermira Inc (DERM) as of December 24, 2019, with a value of $94,706 and a weighting of 7.82%. The other 3 stocks Neumora Therapeutics Inc (NMRA) , Atara Biotherapeutics Inc (ATRA) , Macrogenics Inc (MGNX) have a combined weighting of 1.77% among all his current holdings.
Latest Holdings of Matthew K Fust
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals Inc | 2024-03-20 | 18,536 | 30.42 | 563,865 |
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-07 | 14,860 | 35.69 | 530,353 |
DERM | Dermira Inc | 2019-12-24 | 5,051 | 18.75 | 94,706 |
NMRA | Neumora Therapeutics Inc | 2024-10-18 | 20,100 | 0.65 | 13,001 |
ATRA | Atara Biotherapeutics Inc | 2021-11-04 | 1,260 | 6.17 | 7,774 |
MGNX | Macrogenics Inc | 2019-02-06 | 500 | 1.26 | 630 |
Holding Weightings of Matthew K Fust
Matthew K Fust Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew K Fust has made a total of 7 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 60,000 shares on March 20, 2024, which brought Matthew K Fust around $3 Million.
According to the SEC Form 4 filings, Matthew K Fust has made a total of 5 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 12,195 shares on March 7, 2024, which brought Matthew K Fust around $620,482.
According to the SEC Form 4 filings, Matthew K Fust has made a total of 0 transactions in Dermira Inc (DERM) over the past 5 years. The most-recent trade in Dermira Inc is the sale of 3,000 shares on December 24, 2019, which brought Matthew K Fust around $45,000.
More details on Matthew K Fust's insider transactions can be found in the Insider Trading History of Matthew K Fust table.Insider Trading History of Matthew K Fust
- 1
Matthew K Fust Trading Performance
Matthew K Fust Ownership Network
Ownership Network List of Matthew K Fust
Ownership Network Relation of Matthew K Fust

Matthew K Fust Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Matthew K Fust is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , EVP and Chief Medical Officer Eric Crombez , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Matthew K Fust made 1 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 12,195. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 266,287 shares made by Emil D Kakkis , a net sale of 58,426 shares made by Thomas Richard Kassberg , and a net sale of 29,398 shares made by Karah Herdman Parschauer .
In summary, during the past 3 months, insiders sold 161,537 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 161,537 shares. During the past 18 months, 428,438 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 428,438 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Matthew K Fust Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew K Fust. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew K Fust's mailing address is: Novato Ca 94949.